BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $12.05 million. The enterprise value is -$5.14 million.
Important Dates
The last earnings date was Friday, August 15, 2025, after market close.
Earnings Date | Aug 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BioVie has 7.53 million shares outstanding. The number of shares has increased by 226.96% in one year.
Current Share Class | 7.53M |
Shares Outstanding | 7.53M |
Shares Change (YoY) | +226.96% |
Shares Change (QoQ) | +0.42% |
Owned by Insiders (%) | 0.45% |
Owned by Institutions (%) | 1.59% |
Float | 7.44M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.16 |
P/TBV Ratio | 0.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.10, with a Debt / Equity ratio of 0.02.
Current Ratio | 9.10 |
Quick Ratio | 8.64 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -54.30 |
Financial Efficiency
Return on equity (ROE) is -101.64% and return on invested capital (ROIC) is -55.11%.
Return on Equity (ROE) | -101.64% |
Return on Assets (ROA) | -48.28% |
Return on Invested Capital (ROIC) | -55.11% |
Return on Capital Employed (ROCE) | -93.67% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.28M |
Employee Count | 13 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.32% in the last 52 weeks. The beta is 1.07, so BioVie's price volatility has been similar to the market average.
Beta (5Y) | 1.07 |
52-Week Price Change | -95.32% |
50-Day Moving Average | 6.80 |
200-Day Moving Average | 14.36 |
Relative Strength Index (RSI) | 21.14 |
Average Volume (20 Days) | 433,974 |
Short Selling Information
The latest short interest is 132,110, so 1.75% of the outstanding shares have been sold short.
Short Interest | 132,110 |
Short Previous Month | 152,820 |
Short % of Shares Out | 1.75% |
Short % of Float | 1.78% |
Short Ratio (days to cover) | 2.17 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -18.07M |
Pretax Income | -36.29M |
Net Income | -17.91M |
EBITDA | -17.84M |
EBIT | -18.07M |
Earnings Per Share (EPS) | -$12.12 |
Full Income Statement Balance Sheet
The company has $17.54 million in cash and $349,894 in debt, giving a net cash position of $17.19 million or $2.28 per share.
Cash & Cash Equivalents | 17.54M |
Total Debt | 349,894 |
Net Cash | 17.19M |
Net Cash Per Share | $2.28 |
Equity (Book Value) | 19.01M |
Book Value Per Share | 9.93 |
Working Capital | 18.42M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -19.03M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |